Paul Song

Company: NKGen Biotech

Job title: Chief Executive Officer & Chairman

Seminars:

Driving Pipelines for Alzheimer’s Disease (AD) & Parkinson’s Disease (PD): Unleashing the Potential of NK Cell Therapies for Neurodegenerative Diseases 10:00 am

Navigating the need novel cell therapies in comparison to other forms of treatment for AD and PD Exploring the newest NK cell therapy data in AD to reveal positive results discovered thus far Planning for the future of NK cell therapies in neurodegenerative diseases to suggest directions for these indicationsRead more

day: Conference Day Two